BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35788071)

  • 1. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions.
    Osanlou R; Walker L; Hughes DA; Burnside G; Pirmohamed M
    BMJ Open; 2022 Jul; 12(7):e055551. PubMed ID: 35788071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.
    Pirmohamed M; James S; Meakin S; Green C; Scott AK; Walley TJ; Farrar K; Park BK; Breckenridge AM
    BMJ; 2004 Jul; 329(7456):15-9. PubMed ID: 15231615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors.
    Asio L; Nasasira M; Kiguba R
    Ther Adv Drug Saf; 2023; 14():20420986231188842. PubMed ID: 37529762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.
    Alhawassi TM; Krass I; Bajorek BV; Pont LG
    Clin Interv Aging; 2014; 9():2079-86. PubMed ID: 25489239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool.
    Parameswaran Nair N; Chalmers L; Peterson GM; Bereznicki BJ; Castelino RL; Bereznicki LR
    Clin Interv Aging; 2016; 11():497-505. PubMed ID: 27194906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of medicines in patients with polypharmacy aged 65-100 in primary care: Large variability in risks of adverse drug related and emergency hospital admissions.
    Fahmi A; Wong D; Walker L; Buchan I; Pirmohamed M; Sharma A; Cant H; Ashcroft DM; van Staa TP
    PLoS One; 2023; 18(2):e0281466. PubMed ID: 36753492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of incidence and clinical characteristics of adverse drug reactions in hospitalized patients.].
    Esteban Jiménez Ó; Navarro Pemán C; González Rubio F; Lanuza Giménez FJ; Montesa Lou C
    Rev Esp Salud Publica; 2017 Dec; 91():. PubMed ID: 29269726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
    Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
    Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.
    Pedrós C; Formiga F; Corbella X; Arnau JM
    Eur J Clin Pharmacol; 2016 Feb; 72(2):219-26. PubMed ID: 26546335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission.
    Pedrós C; Quintana B; Rebolledo M; Porta N; Vallano A; Arnau JM
    Eur J Clin Pharmacol; 2014 Mar; 70(3):361-7. PubMed ID: 24362489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
    Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
    BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.
    Wu TY; Jen MH; Bottle A; Molokhia M; Aylin P; Bell D; Majeed A
    J R Soc Med; 2010 Jun; 103(6):239-50. PubMed ID: 20513902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study.
    Doherty AS; Boland F; Moriarty F; Fahey T; Wallace E
    Br J Gen Pract; 2023 Mar; 73(728):e211-e219. PubMed ID: 36823047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria.
    Oshikoya KA; Chukwura H; Njokanma OF; Senbanjo IO; Ojo I
    Sao Paulo Med J; 2011 May; 129(3):153-64. PubMed ID: 21755250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital.
    Walsh D; Lavan A; Cushen AM; Williams D
    Ir J Med Sci; 2015 Jun; 184(2):441-7. PubMed ID: 24899068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and cost of serious adverse drug reactions in a department of general medicine.
    Moore N; Lecointre D; Noblet C; Mabille M
    Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoidable hospitalizations due to adverse drug reactions in an acute geriatric unit. Analysis of 3,292 patients.
    Cabré M; Elias L; Garcia M; Palomera E; Serra-Prat M
    Med Clin (Barc); 2018 Mar; 150(6):209-214. PubMed ID: 28992984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, seriousness and effect of previous adverse drug reactions on prescribing during acute medical admission.
    Acheampong P; Doig JC; Doshi M
    Int J Clin Pharm; 2012 Dec; 34(6):871-5. PubMed ID: 22864868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.